These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Histological differentiation between palmoplantar pustulosis and pompholyx. Yoon SY; Park HS; Lee JH; Cho S J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):889-93. PubMed ID: 22691103 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment. Wolk K; Wilsmann-Theis D; Witte K; Brembach TC; Kromer C; Gerdes S; Ghoreschi K; Reich K; Mössner R; Sabat R Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674793 [TBL] [Abstract][Full Text] [Related]
48. Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis. Terui H; Moroi R; Masamune A; Aiba S; Yamasaki K Case Rep Dermatol; 2023; 15(1):22-25. PubMed ID: 36726801 [TBL] [Abstract][Full Text] [Related]
49. Pustulosis palmoplantaris is a disease distinct from psoriasis. de Waal AC; van de Kerkhof PC J Dermatolog Treat; 2011 Apr; 22(2):102-5. PubMed ID: 20687846 [TBL] [Abstract][Full Text] [Related]
50. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study. Mrowietz U; Burden AD; Pinter A; Reich K; Schäkel K; Baum P; Datsenko Y; Deng H; Padula SJ; Thoma C; Bissonnette R Dermatol Ther (Heidelb); 2021 Apr; 11(2):571-585. PubMed ID: 33661508 [TBL] [Abstract][Full Text] [Related]
51. Clinical outcome of tonsillectomy for palmoplantar pustulosis and etiological relationship between palmoplantar pustulosis and tonsils. Takahara M Adv Otorhinolaryngol; 2011; 72():86-8. PubMed ID: 21865698 [TBL] [Abstract][Full Text] [Related]
52. A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis. Bissonnette R; Maari C; Tsianakas A; Reid D; McCutchan S; Baumgartner S; Mackay J; Bhakta N Dermatol Ther (Heidelb); 2021 Dec; 11(6):2179-2193. PubMed ID: 34716902 [TBL] [Abstract][Full Text] [Related]
53. UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study. Su LN; Ren J; Cheng SM; Liu JL; Ding YF; Zhu NW Lasers Med Sci; 2017 Nov; 32(8):1819-1823. PubMed ID: 28699044 [TBL] [Abstract][Full Text] [Related]
54. Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis. Murakami M; Ohtake T; Horibe Y; Ishida-Yamamoto A; Morhenn VB; Gallo RL; Iizuka H J Invest Dermatol; 2010 Aug; 130(8):2010-6. PubMed ID: 20393482 [TBL] [Abstract][Full Text] [Related]
55. Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris. Bissonnette R; Suárez-Fariñas M; Li X; Bonifacio KM; Brodmerkel C; Fuentes-Duculan J; Krueger JG PLoS One; 2016; 11(5):e0155215. PubMed ID: 27152848 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis. Fujisawa T; Tawada C; Mizutani Y; Doi T; Yoshida S; Ogura S; Seishima M Ther Apher Dial; 2014 Jun; 18(3):238-43. PubMed ID: 24965289 [TBL] [Abstract][Full Text] [Related]
57. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study. Bissonnette R; Poulin Y; Guenther L; Lynde CW; Bolduc C; Nigen S J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1402-8. PubMed ID: 21349113 [TBL] [Abstract][Full Text] [Related]
58. Apremilast monotherapy for palmoplantar pustulosis: Report of three cases. Marovt M; Marko PB SAGE Open Med Case Rep; 2021; 9():2050313X211034926. PubMed ID: 34394938 [TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics and associations of palmoplantar pustulosis: an observational study. Oktem A; Uysal PI; Akdoğan N; Tokmak A; Yalcin B An Bras Dermatol; 2020; 95(1):15-19. PubMed ID: 31899067 [TBL] [Abstract][Full Text] [Related]
60. Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions. Masuda-Kuroki K; Kawakami H; Abe N; Mori M; Tobita R; Fukushi R; Hiruma J; Takeda Y; Okubo Y J Dermatol Sci; 2022 Apr; 106(1):29-36. PubMed ID: 35307234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]